Mutant and native human β-amyloid precursor proteins in transgenic mouse brain

David S. Howland, Mary J. Savage, Frederick A. Huntress, Racheal E. Wallace, Daniel A. Schwartz, Tatjana Loh, Richard H. Melloni, Louis J. Degennaro, Barry D. Greenberg, Robert Siman, Mark E. Swanson, Richard W. Scott

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


Human β-amyloid precursor protein (βAPP) has been targeted to transgenic neurons using synapsin I promoter-based chimeric transgenes. Native human βAPP was introduced as well as βAPP containing mutations genetically linked to familial Alzheimer's disease (AD) and to hereditary cerebral hemorrhage with amyloidosis-Dutch type. In mouse brain, human βAPP RNA was up to 60% as abundant as total endogenous βAPP RNA. Human βAPP gene expression was most abundant in the CA subfields of the hippocampus and in the piriform cortex. Correct processing of human βAPP at the β-secretase cleavage site was demonstrated in transgenic mouse brains. Despite a 40% increase in total βAPP immunoreactivity in lines expressing mutant human βAPP, no evidence of amyloid deposition was found in brains of mice up to 14 months in age. Higher levels of mutant human βAPP, increased age, or other factors may be necessary to elicit β-amyloid-related neuropathologies in the rodent brain.

Original languageEnglish (US)
Pages (from-to)685-699
Number of pages15
JournalNeurobiology of aging
Issue number4
StatePublished - 1995
Externally publishedYes


  • Alzheimer's disease
  • Synapsin I promoter
  • Transgenic mice
  • β-amyloid precursor protein

ASJC Scopus subject areas

  • General Neuroscience
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology


Dive into the research topics of 'Mutant and native human β-amyloid precursor proteins in transgenic mouse brain'. Together they form a unique fingerprint.

Cite this